Work

Circulating Tumor DNA and Immune Biomarkers for Predicting Treatment Response and Min-imal Residual Disease in Cancer: A Systematic Review and Meta-analysis

Year: 2026
Type: review
Abstract: Background: Circulating tumour DNA (ctDNA) may detect minimal residual disease (MRD) after curative-intent therapy and capture early response to immune checkpoint inhibitors (ICIs). We quantified its prognostic value in both settings. Methods: This review was registered in PROSPERO (CRD420261530226). Following PRISMA 2020, PubMed/MEDLINE, Embase, the Cochrane Library and Web of Science were searched for studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) for (A) recurrence in ctDNA-positive versus ctDNA-negative patients after curative-intent treatment and (B) overall survival (OS) in ctDNA molecular responders versus non-responders on ICIs. HRs were pooled with DerSimonian–Laird random-effects models, with Hartung–Knapp–Sidik–Jonkman, subgroup, leave-one-out and small-study-effect analyses. Results: Thirty studies were included; 16 were pooled. In meta-analysis A (10 studies; 2,592 patients; colorectal, lung, urothelial and breast cancer), post-treatment ctDNA positivity was associated with recurrence (HR 8.73, 95% CI 6.92–11.00; I² = 24.5%; prediction interval 5.35–14.25). The association was consistent in colorectal (HR 9.77) and other cancers (HR 7.56). In meta-analysis B (6 studies; 387 patients), early ctDNA molecular response on ICIs was associated with longer OS (HR 0.29, 95% CI 0.22–0.39; I² = 0%). Response rates were 61–77% in molecular responders versus about 6% in non-responders. Fourteen non-poolable studies were directionally concordant. Conclusions: Post-treatment ctDNA is a strong, consistent predictor of recurrence across solid tumours, and early ctDNA clearance on ICIs identifies patients likely to derive survival benefit. Integrating ctDNA with circulating immune biomarkers merits prospective validation in biomarker-guided trials.
Language: English
Subfield: Cancer Research
Open Access status: diamond
OpenAlex ID: W7221268168
FWCI:
Cites: 37
Cited by:
Related to: 10